Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    M. Alexander Otto, PA, MMS

    News

    Hepatic infusion pumps: New enthusiasm for an old technology

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: January 24, 2024

    The response with the pump is “clearly superior” to systemic treatment, according to the author a new study.

    • Read More

    News

    Immunotherapy Combo Wins Big on PFS in First-Line Mets CRC

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: January 23, 2024

    The findings of a new study indicate that nivolumab plus ipilimumab should really be “a new standard,” a medical oncologist says.

    • Read More

    News

    Radiation Oncologists Fight for Payment Reform Amid Cuts

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: January 19, 2024

    Over the past decade, radiation oncologists have seen a 23% drop in Medicare reimbursement for...

    • Read More

    News

    FDA Rejects GI Cancer Drug Over Manufacturing Issues

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: January 12, 2024

    Zolbetuximab was under priority review as the first agent specifically for locally advanced unresectable or metastatic HER2-negative gastric or...

    • Read More

    News

    Magnetic Seeds or Guidewires for Breast Cancer Localization?

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: January 5, 2024

    Paramagnetic seeds work just as well as standard guidewires and are easier to use.

    • Read More

    News

    Pregnancy safe after BRCA-mutated breast cancer

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: December 18, 2023

    Although pregnancy after breast cancer is considered safe in general, little data exist for BRCA carriers.

    • Read More

    News

    Oncotype Score Helps Avoid Unnecessary Radiation in DCIS

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: December 12, 2023

    Using a gene test to guide radiation decisions may reduce overtreatment in ductal carcinoma in situ.

    • Read More

    News

    When to skip regional nodal radiation in breast cancer

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: December 7, 2023

    “Based on the data, it’s a reasonable conclusion that radiotherapy can be avoided.”

    • Read More

    News

    ASCO details how to manage ongoing cancer drug shortage

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: December 1, 2023

    “This guidance document aims to support clinicians, as they navigate the complexities of treatment planning amid the drug shortage.”

    • Read More

    News

    FDA OKs new agent to block chemotherapy-induced neutropenia

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: November 29, 2023

    Efbemalenograstim has been approved by the FDA to combat infections in adults being treated for nonmyeloid cancers.

    • Read More

    News

    Surgery is falling out of favor in rectal cancer

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: November 21, 2023

    “This case series shows that rectal cancer is increasingly being managed medically,” the authors said.

    • Read More

    News

    Low vitamin D linked to paclitaxel-induced peripheral neuropathy

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: November 8, 2023

    These results also “suggest that vitamin D supplementation in patients with lower levels of vitamin D may reduce peripheral neuropathy ...”

    • Read More

    News

    This tool can predict recurrence in rectal cancer watchful waiting

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: November 2, 2023

    This validation study confirms that the Immunoscore biopsy “is an independent parameter predicting time to recurrence” and can help physicians and...

    • Read More

    News

    Stripped privileges: An alarming precedent for community oncologists?

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: November 2, 2023

    The outcome, some community oncologists say, could set a new precedent in how far large health care organizations will go to take their patients...

    • Read More

    News

    FDA OKs ivosidenib for IDH1-mutated myelodysplastic syndromes

    Author:
    M. Alexander Otto, PA, MMS
    Publish date: October 25, 2023

    For adults with a rare form of myelodysplastic syndromes, the FDA has approved a targeted therapy called ivosidenib.

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery